Dunn Gordon 4
4 · Quoin Pharmaceuticals, Ltd. · Filed Sep 11, 2024
Insider Transaction Report
Form 4
Dunn Gordon
Chief Financial Officer
Transactions
- Purchase
Ordinary Shares
2024-09-10$0.91/sh+10,000$9,100→ 18,856 total - Purchase
Ordinary Shares
2024-09-10$0.71/sh+10,000$7,100→ 28,856 total - Purchase
Ordinary Shares
2024-09-09$0.80/sh+4,000$3,200→ 8,856 total - Purchase
Ordinary Shares
2024-09-09$0.78/sh+4,000$3,120→ 4,856 total - Purchase
Ordinary Shares
2024-09-09$0.80/sh+856$685→ 856 total
Footnotes (1)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer.